Study: Formularies may be key to alleviating opioid epidemicNew Yale University research offers stunning findings about drug formulary coverage and prescribing opioids.
Top four approaches to reduce pharmaceutical costs
Top four approaches to reduce pharmaceutical costsMCOs are fighting back against rising pharmaceutical costs. Here are the top strategies they are embracing.
Opinion: Hospital formularies can play key role in reducing opioid epidemicAdding non-opioid postsurgical options to hospital formularies should be a top consideration.
What billions in lost pharma revenue means for managed carePharmaceutical manufacturer relationships and next-gen value based contracts are primed to accelerate value-derivation from your drug spend.
What executives must know to combat rising drug spendIn today’s healthcare landscape, few things better define the role of a managed healthcare executive than managing the industry’s constant changes.
Adding biosimilars to formularies: The pharmacist's rolePharmacists on P&T committees are going to face issues that range from biosimilar naming systems to challenges in dispensing and costs.
Control of the pharmacy benefit is in play with Medicaid expansionDespite the influx of enrollees into managed Medicaid plans as a result of Medicaid expansion, more states are maintaining control of the pharmacy benefit by aligning managed care formularies with the state's current preferred drug list.
Closed formularies hold the line on costsHealth plans struggling to rein in pharmacy costs are using mail service, disease management programs, financial incentives for generics, member cost sharing, and, increasingly, limited and closed formularies.
The future of formulariesExperts anticipate plans with up to seven levels
PBMs play role in personalizing medications for childrenPharmacy benefits managers are paying attention to medications that specifically target children